Nucynta Tablet, Film Coated, Extended Release
Product Images NDC 24510-174

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Nucynta (NDC 24510-174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Collegium Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Nucynta 01)

Chemical structure diagram of tapentadol hydrochloride, showing the molecular arrangement including a phenol group and an amine with hydrochloride salt indicated.*

FDA Label Image

Figure 1 (Nucynta 02)

A cumulative distribution plot showing percent improvement in pain from baseline at week 15 during treatment. The x-axis represents percent improvement in pain with intervals from >0 to 100, and the y-axis represents the percent of patients improved, ranging from 0 to 100%. Two curves are shown: a dashed line for Nucynta ER and a solid line for placebo, with vertical dashed lines at 30% and 50% improvement benchmarks.*

FDA Label Image

Figure 2 (Nucynta 03)

A line graph showing the percent improvement in pain from baseline at week 12 of the double-blind period. The graph compares Nucynta ER (tapentadol hydrochloride extended-release tablets) with placebo, plotting percent improvement in pain on the x-axis against the percent of patients improved on the y-axis. Nucynta ER is represented by a dashed line, and placebo by a solid line.*

FDA Label Image

Figure 3 (Nucynta 04)

A line graph comparing percent improvement in pain from baseline at week 12 between Nucynta ER and placebo groups during a double-blind period. The x-axis shows percent improvement in pain from 0 to 100%, and the y-axis shows the percent of patients improved from 0 to 100%. Two lines represent placebo and Nucynta ER patient responses across various improvement thresholds.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Label)

Nucynta ER 50 mg extended release tablets package label showing 60 film-coated tablets. The label displays the active ingredient tapentadol, dosage strength 50 mg per tablet, and administration instructions to swallow tablets whole without chewing, crushing, or dissolving. It includes prescribing cautions and storage information. The labeler is Collegium Pharmaceutical, Inc.*

FDA Label Image

Principal Display Panel (100 mg Tablet Bottle Label)

Nucynta ER 100 mg extended-release tablets packaging label. The label shows the proprietary name Nucynta ER with the generic name tapentadol. It indicates oral tablet dosage form with a strength of 100 mg. The package contains 60 tablets. The labeler is Collegium Pharmaceutical, Inc. Usage instructions mention swallowing tablets whole.*

FDA Label Image

Principal Display Panel (150 mg Tablet Bottle Label)

Label for Nucynta ER 150 mg extended-release tablets, containing tapentadol hydrochloride. This oral, film-coated tablet package contains 60 tablets. Label shows the NDC 24510-174-60 and identifies Collegium Pharmaceutical, Inc. as the manufacturer. The label includes administration instructions to swallow tablets whole and federal caution against transferring the drug to others.*

FDA Label Image

Principal Display Panel (200 mg Tablet Bottle Label)

Nucynta ER 200 mg extended release tablets label featuring tapentadol as the active ingredient. The film-coated tablets are oral dosage form packaged in a 60-tablet quantity. The label includes the NDC 24510-232-60 and manufacturing information from Collegium Pharmaceutical, Inc. It specifies the medication is prescription-only and contains warnings about proper use and storage.*

FDA Label Image

Principal Display Panel (250 mg Tablet Bottle Label)

Nucynta ER 250 mg Extended Release Tablets label for oral use, containing tapentadol. The label indicates a bottle of 60 film-coated tablets from Collegium Pharmaceutical, Inc. It includes usage instructions, storage conditions, and a caution about drug transfer restrictions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.